Dana Investment Advisors, Inc. Sage Therapeutics, Inc. Transaction History

Dana Investment Advisors, Inc.

  • $2.93 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$40.26 - $57.37 $571,893 - $814,940
-14,205 Closed
0 $0
Q2 2021

Aug 10, 2021
BUY
$54.88 - $79.29 $166,451 - $240,486
3,033 Added 27.15%
14,205 $807,000
Q1 2021

May 13, 2021
BUY
$70.65 - $96.76 $789,301 - $1.08 Million
11,172 New
11,172 $836,000

Others Institutions Holding SAGE

# of Institutions
218
Shares Held
48.2M
Call Options Held
854K
Put Options Held
195K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $395M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Dana Investment Advisors, Inc. Portfolio

Follow Dana Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email